Spider venom-derived peptide induces hyperalgesia in Na
Amino Acid Sequence
Animals
Female
Ganglia, Spinal
/ pathology
Humans
Hyperalgesia
/ chemically induced
Ion Channel Gating
Male
Mice, Knockout
NAV1.7 Voltage-Gated Sodium Channel
/ chemistry
NAV1.8 Voltage-Gated Sodium Channel
/ metabolism
NAV1.9 Voltage-Gated Sodium Channel
/ chemistry
Neurons
/ drug effects
Pain
/ complications
Peptides
/ adverse effects
Rats
Spider Venoms
/ adverse effects
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
08 05 2020
08 05 2020
Historique:
received:
28
07
2019
accepted:
21
04
2020
entrez:
10
5
2020
pubmed:
10
5
2020
medline:
6
8
2020
Statut:
epublish
Résumé
The sodium channels Na
Identifiants
pubmed: 32385249
doi: 10.1038/s41467-020-16210-y
pii: 10.1038/s41467-020-16210-y
pmc: PMC7210961
doi:
Substances chimiques
NAV1.7 Voltage-Gated Sodium Channel
0
NAV1.8 Voltage-Gated Sodium Channel
0
NAV1.9 Voltage-Gated Sodium Channel
0
Peptides
0
Scn10a protein, mouse
0
Scn11a protein, mouse
0
Scn9a protein, mouse
0
Spider Venoms
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2293Références
Treede, R. D. The international association for the study of pain definition of pain: as valid in 2018 as in 1979, but in need of regularly updated footnotes. Pain Rep. 3, e643 (2018).
pubmed: 29756089
pmcid: 5902252
doi: 10.1097/PR9.0000000000000643
Cox, J. J. et al. An SCN9A channelopathy causes congenital inability to experience pain. Nature 444, 894–898 (2006).
pubmed: 17167479
doi: 10.1038/nature05413
pmcid: 17167479
Leipold, E. et al. A de novo gain-of-function mutation in SCN11A causes loss of pain perception. Nat. Genet. 45, 1399–1404 (2013).
pubmed: 24036948
doi: 10.1038/ng.2767
pmcid: 24036948
Chen, Y. C. et al. Transcriptional regulator PRDM12 is essential for human pain perception. Nat. Genet. 47, 803–808 (2015).
pubmed: 26005867
doi: 10.1038/ng.3308
pmcid: 26005867
Nilsen, K. B. et al. Two novel SCN9A mutations causing insensitivity to pain. Pain 143, 155–158 (2009).
pubmed: 19304393
doi: 10.1016/j.pain.2009.02.016
pmcid: 19304393
Cox, J. J. et al. Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations. Hum. Mutat. 31, E1670–E1686 (2010).
pubmed: 20635406
doi: 10.1002/humu.21325
pmcid: 20635406
Yang, Y. et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J. Med. Genet. 41, 171–174 (2004).
pubmed: 14985375
pmcid: 1735695
doi: 10.1136/jmg.2003.012153
Fertleman, C. R. et al. SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes. Neuron 52, 767–774 (2006).
pubmed: 17145499
doi: 10.1016/j.neuron.2006.10.006
pmcid: 17145499
Dib-Hajj, S. D., Yang, Y., Black, J. A. & Waxman, S. G. The Na(V)1.7 sodium channel: from molecule to man. Nat. Rev. Neurosci. 14, 49–62 (2013).
pubmed: 23232607
doi: 10.1038/nrn3404
Cao, L. et al. Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia. Sci. Transl. Med. 8, 335ra356 (2016).
doi: 10.1126/scitranslmed.aad7653
McDonnell, A. et al. Efficacy of the Nav1.7 blocker PF-05089771 in a randomised, placebo-controlled, double-blind clinical study in subjects with painful diabetic peripheral neuropathy. Pain 159, 1465–1476 (2018).
pubmed: 29578944
doi: 10.1097/j.pain.0000000000001227
Zakrzewska, J. M. et al. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial. Lancet. Neurol. 16, 291–300 (2017).
pubmed: 28216232
doi: 10.1016/S1474-4422(17)30005-4
Kingwell, K. Nav1.7 withholds its pain potential. Nat. Rev. Drug Discov. https://doi.org/10.1038/d41573-019-00065-0 (2019).
Dib-Hajj, S. D., Cummins, T. R., Black, J. A. & Waxman, S. G. Sodium channels in normal and pathological pain. Annu. Rev. Neurosci. 33, 325–347 (2010).
pubmed: 20367448
doi: 10.1146/annurev-neuro-060909-153234
pmcid: 20367448
Han, C., Huang, J. & Waxman, S. G. Sodium channel Nav1.8: emerging links to human disease. Neurology 86, 473–483 (2016).
pubmed: 26747884
doi: 10.1212/WNL.0000000000002333
pmcid: 26747884
Zhang, X. Y. et al. Gain-of-function mutations in SCN11A cause familial episodic pain. Am. J. Hum. Genet. 93, 957–966 (2013).
pubmed: 24207120
pmcid: 3824123
doi: 10.1016/j.ajhg.2013.09.016
Faber, C. G. et al. Gain-of-function Nav1.8 mutations in painful neuropathy. Proc. Natl Acad. Sci. USA 109, 19444–19449 (2012).
pubmed: 23115331
doi: 10.1073/pnas.1216080109
pmcid: 23115331
Rush, A. M., Cummins, T. R. & Waxman, S. G. Multiple sodium channels and their roles in electrogenesis within dorsal root ganglion neurons. J. Physiol. 579, 1–14 (2007).
pubmed: 17158175
doi: 10.1113/jphysiol.2006.121483
pmcid: 17158175
Renganathan, M., Cummins, T. R. & Waxman, S. G. Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. J. Neurophysiol. 86, 629–640 (2001).
pubmed: 11495938
doi: 10.1152/jn.2001.86.2.629
pmcid: 11495938
Baker, M. D., Chandra, S. Y., Ding, Y., Waxman, S. G. & Wood, J. N. GTP-induced tetrodotoxin-resistant Na+ current regulates excitability in mouse and rat small diameter sensory neurones. J. Physiol. 548, 373–382 (2003).
pubmed: 12651922
pmcid: 2342858
doi: 10.1113/jphysiol.2003.039131
Osteen, J. D. et al. Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain. Nature 534, 494–499 (2016).
pubmed: 27281198
pmcid: 4919188
doi: 10.1038/nature17976
Osteen, J. D., Sampson, K., Iyer, V., Julius, D. & Bosmans, F. Pharmacology of the Nav1.1 domain IV voltage sensor reveals coupling between inactivation gating processes. Proc. Natl Acad. Sci. USA 114, 6836–6841 (2017).
pubmed: 28607094
Richards, K. L. et al. Selective NaV1.1 activation rescues Dravet syndrome mice from seizures and premature death. Proc. Natl Acad. Sci. USA 115, E8077–E8085 (2018).
pubmed: 30076230
doi: 10.1073/pnas.1804764115
Chugunov, A. O. et al. Modular organization of alpha-toxins from scorpion venom mirrors domain structure of their targets, sodium channels. J. Biol. Chem. 288, 19014–19027 (2013).
pubmed: 23637230
pmcid: 3696675
doi: 10.1074/jbc.M112.431650
Ekberg, J. et al. muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc. Natl Acad. Sci. USA 103, 17030–17035 (2006).
pubmed: 17077153
doi: 10.1073/pnas.0601819103
Yang, S. et al. Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models. Proc. Natl Acad. Sci. USA 110, 17534–17539 (2013).
pubmed: 24082113
doi: 10.1073/pnas.1306285110
Kalia, J. et al. From foe to friend: using animal toxins to investigate ion channel function. J. Mol. Biol. 427, 158–175 (2015).
pubmed: 25088688
doi: 10.1016/j.jmb.2014.07.027
Catterall, W. A. et al. Voltage-gated ion channels and gating modifier toxins. Toxicon 49, 124–141 (2007).
pubmed: 17239913
doi: 10.1016/j.toxicon.2006.09.022
Sanguinetti, M. C. et al. Heteropodatoxins: peptides isolated from spider venom that block Kv4.2 potassium channels. Mol. Pharmacol. 51, 491–498 (1997).
pubmed: 9058605
Nassar, M. A. et al. Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain. Proc. Natl Acad. Sci. USA 101, 12706–12711 (2004).
pubmed: 15314237
doi: 10.1073/pnas.0404915101
pmcid: 15314237
Minett, M. S. et al. Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons. Nat. Commun. 3, 791 (2012).
pubmed: 22531176
pmcid: 3337979
doi: 10.1038/ncomms1795
Hu, H. J. et al. The kv4.2 potassium channel subunit is required for pain plasticity. Neuron 50, 89–100 (2006).
pubmed: 16600858
doi: 10.1016/j.neuron.2006.03.010
pmcid: 16600858
Phuket, T. R. & Covarrubias, M. Kv4 channels underlie the subthreshold-operating A-type K-current in nociceptive dorsal root ganglion neurons. Front. Mol. Neurosci. 2, 3 (2009).
pubmed: 19668710
pmcid: 2724030
doi: 10.3389/neuro.02.003.2009
Vasylyev, D. V., Han, C., Zhao, P., Dib-Hajj, S. & Waxman, S. G. Dynamic-clamp analysis of wild-type human Nav1.7 and erythromelalgia mutant channel L858H. J. Neurophysiol. 111, 1429–1443 (2014).
pubmed: 24401712
doi: 10.1152/jn.00763.2013
pmcid: 24401712
Bosmans, F., Milescu, M. & Swartz, K. J. Palmitoylation influences the function and pharmacology of sodium channels. Proc. Natl Acad. Sci. USA 108, 20213–20218 (2011).
pubmed: 22123950
doi: 10.1073/pnas.1108497108
pmcid: 22123950
Zhang, M. M. et al. Co-expression of Na(V)beta subunits alters the kinetics of inhibition of voltage-gated sodium channels by pore-blocking mu-conotoxins. Br. J. Pharmacol. 168, 1597–1610 (2013).
pubmed: 23146020
pmcid: 3605869
doi: 10.1111/bph.12051
Salvatierra, J. et al. A disease mutation reveals a role for NaV1.9 in acute itch. J. Clin. Investig. 128, 5434–5447 (2018).
pubmed: 30395542
doi: 10.1172/JCI122481
Stevens, M., Peigneur, S. & Tytgat, J. Neurotoxins and their binding areas on voltage-gated sodium channels. Front. Pharmacol. 2, 71 (2011).
pubmed: 22084632
pmcid: 3210964
doi: 10.3389/fphar.2011.00071
Campos, F. V., Chanda, B., Beirao, P. S. & Bezanilla, F. Alpha-scorpion toxin impairs a conformational change that leads to fast inactivation of muscle sodium channels. J. Gen. Physiol. 132, 251–263 (2008).
pubmed: 18663133
pmcid: 2483334
doi: 10.1085/jgp.200809995
Capes, D. L., Goldschen-Ohm, M. P., Arcisio-Miranda, M., Bezanilla, F. & Chanda, B. Domain IV voltage-sensor movement is both sufficient and rate limiting for fast inactivation in sodium channels. J. Gen. Physiol. 142, 101–112 (2013).
pubmed: 23858005
pmcid: 3727307
doi: 10.1085/jgp.201310998
Xiao, Y. et al. Tarantula huwentoxin-IV inhibits neuronal sodium channels by binding to receptor site 4 and trapping the domain ii voltage sensor in the closed configuration. J. Biol. Chem. 283, 27300–27313 (2008).
pubmed: 18628201
pmcid: 2556013
doi: 10.1074/jbc.M708447200
Liu, Z. et al. Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana. J. Biol. Chem. 288, 20392–20403 (2013).
pubmed: 23703613
pmcid: 3711305
doi: 10.1074/jbc.M112.426627
Cummins, T. R., Howe, J. R. & Waxman, S. G. Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channel. J. Neurosci. 18, 9607–9619 (1998).
pubmed: 9822722
pmcid: 6793269
doi: 10.1523/JNEUROSCI.18-23-09607.1998
Herzog, R. I., Cummins, T. R. & Waxman, S. G. Persistent TTX-resistant Na+ current affects resting potential and response to depolarization in simulated spinal sensory neurons. J. Neurophysiol. 86, 1351–1364 (2001).
pubmed: 11535682
doi: 10.1152/jn.2001.86.3.1351
Rush, A. M. et al. A single sodium channel mutation produces hyper- or hypoexcitability in different types of neurons. Proc. Natl Acad. Sci. USA 103, 8245–8250 (2006).
pubmed: 16702558
doi: 10.1073/pnas.0602813103
Huang, J. et al. Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability. J. Clin. Investig. 127, 2805–2814 (2017).
pubmed: 28530638
doi: 10.1172/JCI92373
Bennett, D. L., Clark, A. J., Huang, J., Waxman, S. G. & Dib-Hajj, S. D. The role of voltage-gated sodium channels in pain signaling. Physiol. Rev. 99, 1079–1151 (2019).
pubmed: 30672368
doi: 10.1152/physrev.00052.2017
Zhou, X. et al. Electrophysiological and pharmacological analyses of Nav1.9 voltage-gated sodium channel by establishing a heterologous expression system. Front. Pharmacol. 8, 852 (2017).
pubmed: 29213238
pmcid: 5702848
doi: 10.3389/fphar.2017.00852
Bonnet, C. et al. Maladaptive activation of Nav1.9 channels by nitric oxide causes triptan-induced medication overuse headache. Nat. Commun. 10, 4253 (2019).
pubmed: 31534133
pmcid: 6751217
doi: 10.1038/s41467-019-12197-3
Huang, J. et al. Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy. Brain 137, 1627–1642 (2014).
pubmed: 24776970
doi: 10.1093/brain/awu079
Leipold, E. et al. Cold-aggravated pain in humans caused by a hyperactive NaV1.9 channel mutant. Nat. Commun. 6, 10049 (2015).
pubmed: 26645915
pmcid: 4686659
doi: 10.1038/ncomms10049
Han, C. et al. Familial gain-of-function Nav1.9 mutation in a painful channelopathy. J. Neurol., Neurosurg., Psychiatry 88, 233–240 (2017).
doi: 10.1136/jnnp-2016-313804
Blair, N. T. & Bean, B. P. Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J. Neurosci. 22, 10277–10290 (2002).
pubmed: 12451128
pmcid: 6758735
doi: 10.1523/JNEUROSCI.22-23-10277.2002
Dib-Hajj, S. D. & Waxman, S. G. Diversity of composition and function of sodium channels in peripheral sensory neurons. Pain 156, 2406–2407 (2015).
pubmed: 26580678
Priest, B. T. et al. Contribution of the tetrodotoxin-resistant voltage-gated sodium channel NaV1.9 to sensory transmission and nociceptive behavior. Proc. Natl Acad. Sci. USA 102, 9382–9387 (2005).
pubmed: 15964986
doi: 10.1073/pnas.0501549102
Maingret, F. et al. Inflammatory mediators increase Nav1.9 current and excitability in nociceptors through a coincident detection mechanism. J. Gen. Physiol. 131, 211–225 (2008).
pubmed: 18270172
pmcid: 2248717
doi: 10.1085/jgp.200709935
Lolignier, S. et al. The Nav1.9 channel is a key determinant of cold pain sensation and cold allodynia. Cell Rep. 11, 1067–1078 (2015).
pubmed: 25959819
doi: 10.1016/j.celrep.2015.04.027
pmcid: 25959819
Dib-Hajj, S. D., Black, J. A. & Waxman, S. G. NaV1.9: a sodium channel linked to human pain. Nat. Rev. Neurosci. 16, 511–519 (2015).
pubmed: 26243570
doi: 10.1038/nrn3977
pmcid: 26243570
Minett, M. S. et al. Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7. Nat. Commun. 6, 8967 (2015).
pubmed: 26634308
pmcid: 4686868
doi: 10.1038/ncomms9967
Fjell, J. et al. Differential role of GDNF and NGF in the maintenance of two TTX-resistant sodium channels in adult DRG neurons. Brain Res. Mol. Brain Res. 67, 267–282 (1999).
pubmed: 10216225
doi: 10.1016/S0169-328X(99)00070-4
Rush, A. M. et al. Contactin regulates the current density and axonal expression of tetrodotoxin-resistant but not tetrodotoxin-sensitive sodium channels in DRG neurons. Eur. J. Neurosci. 22, 39–49 (2005).
pubmed: 16029194
doi: 10.1111/j.1460-9568.2005.04186.x
Liu, C. J. et al. Direct interaction with contactin targets voltage-gated sodium channel Na(v)1.9/NaN to the cell membrane. J. Biol. Chem. 276, 46553–46561 (2001).
pubmed: 11581273
doi: 10.1074/jbc.M108699200
Rush, A. M. & Waxman, S. G. PGE2 increases the tetrodotoxin-resistant Nav1.9 sodium current in mouse DRG neurons via G-proteins. Brain Res. 1023, 264–271 (2004).
pubmed: 15374752
doi: 10.1016/j.brainres.2004.07.042
Ostman, J. A., Nassar, M. A., Wood, J. N. & Baker, M. D. GTP up-regulated persistent Na+ current and enhanced nociceptor excitability require NaV1.9. J. Physiol. 586, 1077–1087 (2008).
pubmed: 18096591
doi: 10.1113/jphysiol.2007.147942